Survival of Patients Evaluated by FDG-PET Before Hepatic Resection for Metastatic Colorectal Carcinoma: A Prospective Database Study
- 1 March 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 233 (3) , 293-299
- https://doi.org/10.1097/00000658-200103000-00001
Abstract
To present the survival results for patients with colorectal carcinoma metastases who have undergone liver resection after being staged by [18F] fluoro-2-deoxy-D-glucose–positron emission tomography (FDG-PET). Hepatic resection is standard therapy for colorectal metastases confined to the liver, but recurrence is common because of the presence of undetected cancer at the time of surgery. FDG-PET is a sensitive diagnostic tool that identifies tumors based on the increased uptake of glucose by tumor cells. To date, no survival results have been reported for patients who have actually had liver resection after being staged by FDG-PET. Forty-three patients with metastatic colorectal cancer were referred for hepatic resection after conventional tumor staging with computed tomography. FDG-PET was performed on all patients. Laparotomy was performed on patients not staged out by PET. Resection was performed at the time of laparotomy unless extrahepatic disease or unresectable hepatic tumors were found. Patients were examined at intervals in the preoperative period. FDG-PET identified additional cancer not seen on computed tomography in 10 patients. Surgery was contraindicated in six of these patients because of the findings on FDG-PET. Laparotomy was performed in 37 patients. In all but two, liver resection was performed. Median follow-up in the 35 patients undergoing resection was 24 months. The Kaplan-Meier estimate of overall survival at 3 years was 77% and the lower 95% confidence limit of this estimate of survival was 60%. This figure is higher than 3-year estimate of survival found in previously published series. The 3-year disease-free survival rate was 40%. Preoperative FDG-PET lessens the recurrence rate in patients undergoing hepatic resection for colorectal metastases to the liver by detection of disease not found on conventional imaging.Keywords
This publication has 29 references indexed in Scilit:
- FDG PET Evaluation of Mucinous NeoplasmsAmerican Journal of Roentgenology, 2000
- Hepatic Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal CancerNew England Journal of Medicine, 1999
- Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastasesThe American Journal of Surgery, 1999
- Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal CancerAnnals of Surgery, 1999
- Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer.Archives of Surgery, 1999
- Liver resection for colorectal liver metastasesEuropean Journal of Surgical Oncology, 1995
- Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases.1988
- Major hepatic resection for colorectal liver metastasesBritish Journal of Surgery, 1987
- Hepatic Resection for Colorectal Liver MetastasesAnnals of Surgery, 1987
- Determinants of survival in liver resection for colorectal secondariesBritish Journal of Surgery, 1986